Mitsuhiro Okano Selected Research

Mitsuhiro Okano Research Topics

Disease

21	Rhinosinusitis 11/2021 - 01/2009
18	Inflammation (Inflammations) 03/2020 - 05/2006
17	Allergic Rhinitis 06/2022 - 01/2004
17	Nasal Polyps (Nasal Polyp) 11/2021 - 04/2009
14	Seasonal Allergic Rhinitis (Hay Fever) 07/2022 - 02/2008
13	Eosinophilia 04/2019 - 01/2004
7	Otitis Media 01/2021 - 05/2013
7	Otitis Media with Effusion 01/2020 - 05/2003
6	Hypersensitivity (Allergy) 07/2022 - 05/2006
5	Asthma (Bronchial Asthma) 06/2022 - 10/2014
3	Hearing Loss (Hearing Impairment) 01/2021 - 05/2005
2	Anaphylaxis (Anaphylactic Shock) 01/2019 - 02/2014
2	Cholesteatoma 01/2016 - 05/2013
2	Middle Ear Cholesteatoma 01/2016 - 05/2013
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2011 - 12/2004
2	Mucocele 03/2007 - 11/2005
1	Atopic Dermatitis (Atopic Eczema) 07/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 07/2022
1	Drug Hypersensitivity (Drug Allergy) 10/2021
1	Heartburn (Pyrosis) 10/2021
1	Eosinophilic Esophagitis 10/2021
1	Disease Progression 10/2020
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 10/2020
1	Lymphangioma (Cavernous Lymphangioma) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Fistula 01/2020
1	Osteoradionecrosis 01/2020
1	Necrotizing Fasciitis 01/2020
1	Abscess 01/2020
1	Chronic Cough 01/2020
1	Lymphadenopathy 12/2019
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2019
1	Multiple Pulmonary Nodules 12/2019
1	Neoplasms (Cancer) 10/2019

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 04/2019 - 03/2006
14	Immunoglobulin E (IgE)IBA 06/2022 - 01/2004
10	AntigensIBA 03/2020 - 01/2004
9	AllergensIBA 06/2022 - 02/2008
8	Immunoglobulin G (IgG)IBA 01/2021 - 01/2004
6	Macrophage Migration-Inhibitory FactorsIBA 01/2020 - 05/2003
6	LipopolysaccharidesIBA 01/2020 - 03/2007
6	Interleukin-17 (Interleukin 17)IBA 01/2016 - 08/2010
6	Interleukin-5 (Interleukin 5)IBA 01/2016 - 03/2006
5	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 06/2012
5	Prostaglandin D2IBA 01/2021 - 05/2006
5	ImmunosorbentsIBA 01/2020 - 03/2007
5	InterleukinsIBA 01/2020 - 03/2006
5	EnzymesIBA 01/2020 - 03/2007
5	Interleukin-10 (Interleukin 10)IBA 07/2018 - 03/2007
5	ProstaglandinsIBA 10/2016 - 05/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2015
4	Enterotoxins (Enterotoxin)IBA 07/2018 - 04/2009
3	TabletsIBA 10/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2018
3	InflammasomesIBA 01/2020 - 01/2016
3	Interleukin-13IBA 01/2016 - 12/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2013 - 05/2003
3	EndotoxinsIBA 07/2008 - 05/2003
3	Histamine (Histamine Dihydrochloride)FDA Link 06/2007 - 03/2006
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 04/2015
2	Nasal SpraysIBA 01/2019 - 06/2012
2	MucinsIBA 01/2019 - 01/2013
2	Immunoglobulins (Immunoglobulin)IBA 08/2015 - 10/2012
2	Prostaglandins DIBA 01/2009 - 04/2008
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2008 - 05/2003
2	Interleukin-4 (Interleukin 4)IBA 04/2008 - 12/2006
2	Interleukin-12 (IL 12)IBA 03/2007 - 12/2006
1	Histamine Antagonists (Antihistamines)IBA 06/2022
1	Dermatophagoides pteronyssinus antigen p 1IBA 06/2022
1	Dermatophagoides pteronyssinus antigen p 2IBA 06/2022
1	Pyridinolcarbamate (P23)IBA 06/2022
1	benralizumabIBA 11/2021
1	Monoclonal AntibodiesIBA 11/2021
1	Proton Pump InhibitorsIBA 10/2021
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 10/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Omalizumab (Xolair)FDA Link 10/2020
1	IgE Receptors (Fc epsilon RI)IBA 03/2020
1	NucleotidesIBA 01/2020
1	MacrolidesIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 12/2019
1	squamous cell carcinoma-related antigenIBA 10/2019
1	fluticasone furoate FDA Link 01/2019
1	SaltsIBA 01/2019

Therapy/Procedure

5	Immunotherapy 07/2021 - 02/2008
3	Drug Therapy (Chemotherapy) 07/2021 - 04/2015
2	Cochlear Implants (Cochlear Implant) 01/2021 - 01/2016
2	Complementary Therapies (Alternative Medicine) 07/2017 - 10/2011
2	Tonsillectomy 01/2011 - 12/2004
1	Contact Lenses 07/2022
1	Denervation 08/2021
1	Operative Surgical Procedures 01/2021
1	Negative-Pressure Wound Therapy 01/2020
1	Injections 01/2019